SPC Life Sciences IPO Details, Review, GMP, Dates, Prices

SPC Life Sciences IPO: SPC Life Sciences are a chemical manufacturing firm driven by research and development (R&D) with an emphasis on long-chain multi-stage processes. Their advanced pharmaceutical intermediates, or Pharma Intermediates, are used in a number of expanding therapeutic areas, such as anti-depressants, cardiovascular, vasodilators (anti-platelet), and anti-psychotics.

SPC Life Sciences IPO Overview

SPC Life Sciences Limited Company Overview
Company Name SPC Life Sciences Limited
IPO Opening Date November, 2023
IPO Closing Date November, 2023
Face Value 10₹ Per Share
Share Price Range [.]₹ – [.]₹ Per Share
Lot Size To Be Announced
GMP Check Here
Issue Type Fresh Issue
Total IPO Issue Size 8,938,870 Shares (Approx)
Fresh Issue Size ₹300 Crores
IPO Listing At NSE And BSE
Share Holding Pre Issue To Be Announced
Share Holding Post Issue To Be Announced
More IPO’s Check Here


SPC Life Sciences IPO Lot Size

Investors may make a minimum offer of [.] shares and an amount greater than that. The minimum and highest investments made by retail investors and HNI in terms of shares and money are shown in the table below.

SPC Life Sciences Limited IPO Lot Size
Minimum Retail Applications 01 Lot
Maximum Retail Applications 13 Lots
Minimum S-HNI Applications 01 Lot
Maximum S-HNI Applications 14 Lots
Maximum B-HNI Applications 68 Lots
Total Shares In Single Lot [.] Shares
Amount For Single Lot


SPC Life Sciences IPO Time Table (Tentative)

The IPO for SPC Life Sciences starts on November, 2023, and ends on November, 2023.

SPC Life Sciences Limited IPO Time Table Complete Details
IPO Initiation Date November, 2023
IPO Ending Date November, 2023
Basis Of Allotment November, 2023
Initiation Of Refund November, 2023
Shares Credit To Demat Account November, 2023
Date Of Listing November, 2023
Cut Off Time For UPI Mandate Confirmation 05:00 PM, November, 2023


SPC Life Sciences IPO Reservation Details

SPC Life Sciences Limited IPO Reservation Overview
Shares Offered To Retailers Not Less Than 35% Of Net Offer
Shares Offered To HNI Not Less Than 15% Of Net Offer
Shares Offered To QIB Not More Than 50% Of Net Offer


SPC Life Sciences Company Financials

SPC Life Sciences Limited Company Financials Information
This Data Is Of 31 March, 2023
Total Revenue 146.44
Assets 61.48₹ Per Equity Share
Profit After Tax N/A
Net Worth N/A
Reserves And Surplus N/A
Debt N/A
All Amount In ₹ Lakh/Crore 


SPC Life Sciences Promoters Holding

Share Holding Pre Issue %
Share Holding Post Issue %


SPC Life Sciences Key Performance Indicators

SPC Life Sciences Limited Key Performance Indicators
KPI Values
Post P/E (X) N/A
EPS 4.30
RoNW 28.00%


Is SPC Life Sciences IPO Contact Details.

SPC Life Sciences Limited Contact Details
Company Address SPC Life Sciences Limited 284/1, 2 & 3, GIDC Estate, Makarpura, Vadodara
Phone +91 2652658894
E-Mail cs@spcls.co.in
Website https://www.spcls.co.in/


Is SPC Life Sciences IPO Good Or Bad To Buy?

One of the top producers of advanced intermediates in India for a number of important APIs is SPC Life Sciences. These APIs include pentoxifylline, amiodaroneHCL, ciprostazol, trazodone, tramadol, and paroxetine.

Some of these products have a substantial market share in India and around the world. They can create Pharma Intermediates and collaborate with pharmaceutical firms that are looking for US FDA-compliant manufacturing facilities to be a part of their supply chain because they have a facility that is approved by the US FDA for 6-Chloro-Hexane-2-One.


What Is The Future Of SPC Life Sciences Stock?

They make research and development investments in order to establish a sustainable edge over their rivals. They have an internal R&D facility at GIDC, Makarpura, Vadodara, in addition to their production sites in Ankleshwar and Dahej (R&D Facility). Research and development center occupies 1,390.46 square meters overall and is furnished with an analytical development laboratory (ADL), infrastructure for research and development, specifications freezing, and the development of an analytical method for Key Starting Material (KSM), in-process intermediates, final products, and other raw materials.


What Is The Objective Of SPC Life Sciences IPO Issue?

The main objective’s of SPC Life Sciences IPO issue are :-

  • Prepayment or payback of some outstanding loans that our company has taken out.
  • Financing needed for our company’s capital expenditure needs as we build up Phase 2 at our Dahej facility to increase the range of pharmaceutical intermediate products offer.
  • Meeting the needs for working capital.
  • General company objectives


How To Apply For SPC Life Sciences IPO?

The SPC Life Sciences IPO application form and payment can both be completed online. Through the net banking feature of your bank account, you can access the ASBA IPO application. UPI IPO applications are provided by brokers who do not offer banking services. On this page, you can get more details on how to apply for an IPO online using Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank, and SBI Bank.


When Is SPC Life Sciences IPO Allotment?

The Allotment Date For SPC Life Sciences IPO Is November, 2023.

Leave a Comment